Peptron
Peptron Inc is a South Korean biopharmaceutical enterprise developing sustained-release peptide and protein therapeutics. The company utilizes its proprietary SmartDepot microparticle technology platform to engineer long-acting drug formulations, advancing candidates for diabetes, obesity, Parkinson's disease, and prostate cancer. Main revenue drivers comprise research technology licensing fees, clinical trial development milestones, active pharmaceutical ingredient sales, and contract formulation services. Peptron serves global biopharmaceutical partners, clinical research institutions, and medical specialists across South Korea, North America, and Europe. The company holds an innovative market position in long-acting sustained-release drug delivery systems. Headquartered in Daejeon, South Korea, Peptron Inc is listed on the KOSDAQ market.
3 of the funds FundTelligence covers report a position in Peptron.
- Legal name
- Peptron Inc
- Sector
- Health Care
- Country
- South Korea
- Funds holding it
- 3
Funds holding Peptron
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)